Global Peripheral Bioabsorbable Stents Market Growth 2025-2031

The global Peripheral Bioabsorbable Stents market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Peripheral Bioabsorbable Stents are bioabsorbable stents used to treat peripheral arterial disease. The characteristic of bioabsorbable stents is that they can be slowly absorbed and metabolized by the body without leaving any residue, thus avoiding the long-term complications caused by metal stents.

Peripheral artery disease is a vascular disease that is common in the lower limbs and abdomen and can lead to intermittent claudication, gangrene and other serious consequences. Traditional treatment methods usually use metal stents to expand narrowed blood vessels, but this treatment method has certain risks, such as complications such as thrombosis, infection, and restenosis. Therefore, bioresorbable stents are widely considered to be a safer and more effective treatment modality.

United States market for Peripheral Bioabsorbable Stents is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Peripheral Bioabsorbable Stents is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Peripheral Bioabsorbable Stents is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Peripheral Bioabsorbable Stents players cover Abbott Cardiovascular, Boston Scientific, KYOTO MEDICAL PLANNING, Elixir Medical, Arterial Remodeling Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Peripheral Bioabsorbable Stents Industry Forecast” looks at past sales and reviews total world Peripheral Bioabsorbable Stents sales in 2024, providing a comprehensive analysis by region and market sector of projected Peripheral Bioabsorbable Stents sales for 2025 through 2031. With Peripheral Bioabsorbable Stents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Bioabsorbable Stents industry.

This Insight Report provides a comprehensive analysis of the global Peripheral Bioabsorbable Stents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peripheral Bioabsorbable Stents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peripheral Bioabsorbable Stents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Bioabsorbable Stents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Bioabsorbable Stents.

This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Bioabsorbable Stents market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
36 Below
36
78

Segmentation by Application:
Peripheral Blood Vessels Damaged
Peripheral Blood Vessels Blockage

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott Cardiovascular
Boston Scientific
KYOTO MEDICAL PLANNING
Elixir Medical
Arterial Remodeling Technologies
Medtronic
Lifetech Scientific
Beijing Advanced Medical Technologies

Key Questions Addressed in this Report

What is the 10-year outlook for the global Peripheral Bioabsorbable Stents market?

What factors are driving Peripheral Bioabsorbable Stents market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Peripheral Bioabsorbable Stents market opportunities vary by end market size?

How does Peripheral Bioabsorbable Stents break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.